Detailed information for compound 898195

Basic information

Technical information
  • TDR Targets ID: 898195
  • Name: methyl 2-[(4-methoxy-6-methylpyrimidin-2-yl)- phenylsulfonylamino]acetate
  • MW: 351.378 | Formula: C15H17N3O5S
  • H donors: 0 H acceptors: 5 LogP: 1.87 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COC(=O)CN(S(=O)(=O)c1ccccc1)c1nc(C)cc(n1)OC
  • InChi: 1S/C15H17N3O5S/c1-11-9-13(22-2)17-15(16-11)18(10-14(19)23-3)24(20,21)12-7-5-4-6-8-12/h4-9H,10H2,1-3H3
  • InChiKey: RRMZRIRFGNXEKC-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • methyl 2-[(4-methoxy-6-methyl-pyrimidin-2-yl)-phenylsulfonyl-amino]acetate
  • 2-[(4-methoxy-6-methyl-2-pyrimidinyl)-phenylsulfonylamino]acetic acid methyl ester
  • 2-[(4-methoxy-6-methyl-pyrimidin-2-yl)-phenylsulfonyl-amino]acetic acid methyl ester
  • methyl 2-[(4-methoxy-6-methyl-pyrimidin-2-yl)-phenylsulfonyl-amino]ethanoate
  • ChemDiv1_002872
  • STOCK1S-27133
  • Oprea1_856569
  • EU-0004466
  • SMR000038982
  • MLS000071148
  • ZINC00849566
  • BAS 01076336

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens survival of motor neuron 2, centromeric Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus survival motor neuron protein 1 Get druggable targets OG5_132873 All targets in OG5_132873
Brugia malayi hypothetical protein Get druggable targets OG5_132873 All targets in OG5_132873
Echinococcus multilocularis survival motor neuron protein 1 Get druggable targets OG5_132873 All targets in OG5_132873
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132873 All targets in OG5_132873
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) low-density lipoprotein receptor repeat class B containing protein 0.0348 1 1
Brugia malayi Fibulin-1 precursor 0.0348 1 1
Loa Loa (eye worm) hypothetical protein 0.0348 1 1
Loa Loa (eye worm) multiple epidermal growth factor-like domains 6 0.0348 1 1
Loa Loa (eye worm) hypothetical protein 0.0348 1 1
Brugia malayi Low-density lipoprotein receptor repeat class B containing protein 0.0348 1 1
Loa Loa (eye worm) hypothetical protein 0.0348 1 1
Loa Loa (eye worm) hypothetical protein 0.0348 1 1
Echinococcus multilocularis laminin 0.0348 1 1
Toxoplasma gondii calcium binding egf domain-containing protein 0.0348 1 0.5
Echinococcus granulosus laminin 0.0348 1 1
Schistosoma mansoni subfamily M12A unassigned peptidase (M12 family) 0.0348 1 0.5
Loa Loa (eye worm) bone morphogenetic protein 1b 0.0348 1 1
Onchocerca volvulus Arrow homolog 0.0348 1 0.5
Toxoplasma gondii calcium binding egf domain-containing protein 0.0348 1 0.5
Echinococcus granulosus Tolloid protein 1 0.0348 1 1
Echinococcus multilocularis fibrillin 1 0.0348 1 1
Echinococcus multilocularis Tolloid protein 1 0.0348 1 1
Loa Loa (eye worm) hypothetical protein 0.0348 1 1
Schistosoma mansoni egf-like domain protein 0.0348 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) = 4.4668 um PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 35.4813 uM PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.